These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20659111)

  • 21. Total synthesis and biological evaluation of jerantinine E.
    Frei R; Staedler D; Raja A; Franke R; Sasse F; Gerber-Lemaire S; Waser J
    Angew Chem Int Ed Engl; 2013 Dec; 52(50):13373-6. PubMed ID: 24127420
    [No Abstract]   [Full Text] [Related]  

  • 22. Interaction of vinca alkaloids with tubulin: a comparison of vinblastine, vincristine, and vinorelbine.
    Lobert S; Vulevic B; Correia JJ
    Biochemistry; 1996 May; 35(21):6806-14. PubMed ID: 8639632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of interaction of vinca alkaloids with tubulin: catharanthine and vindoline.
    Prakash V; Timasheff SN
    Biochemistry; 1991 Jan; 30(3):873-80. PubMed ID: 1988072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of tubulin-microtubule polymerization by drugs of the Vinca alkaloid class.
    Owellen RJ; Hartke CA; Dickerson RM; Hains FO
    Cancer Res; 1976 Apr; 36(4):1499-502. PubMed ID: 1260766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Triarylaminium Radical Cation Promoted Coupling of Catharanthine with Vindoline: Diastereospecific Synthesis of Anhydrovinblastine and Reaction Scope.
    Boon BA; Boger DL
    J Am Chem Soc; 2019 Sep; 141(36):14349-14355. PubMed ID: 31442047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, molecular modeling and biological evaluation of dithiocarbamates as novel antitubulin agents.
    Qian Y; Ma GY; Yang Y; Cheng K; Zheng QZ; Mao WJ; Shi L; Zhao J; Zhu HL
    Bioorg Med Chem; 2010 Jun; 18(12):4310-6. PubMed ID: 20493717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elaboration of vinblastine hybrids using a reactive in situ generated N-carboxyanhydride.
    Rannoux C; Roussi F; Martin MT; Guéritte F
    Org Biomol Chem; 2011 Jul; 9(13):4873-81. PubMed ID: 21607276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural products which interact with tubulin in the vinca domain: maytansine, rhizoxin, phomopsin A, dolastatins 10 and 15 and halichondrin B.
    Hamel E
    Pharmacol Ther; 1992; 55(1):31-51. PubMed ID: 1287674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrapotent vinblastines in which added molecular complexity further disrupts the target tubulin dimer-dimer interface.
    Carney DW; Lukesh JC; Brody DM; Brütsch MM; Boger DL
    Proc Natl Acad Sci U S A; 2016 Aug; 113(35):9691-8. PubMed ID: 27512044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The binding of vinca domain agents to tubulin: structural and biochemical studies.
    Cormier A; Knossow M; Wang C; Gigant B
    Methods Cell Biol; 2010; 95():373-90. PubMed ID: 20466145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological properties of a new alpha-aminophosphonic acid derivative of vinblastine.
    Pierré A; Lavielle G; Hautefaye P; Seurre G; Leonce S; Saint-Dizier D; Boutin JA; Cudennec CA
    Anticancer Res; 1990; 10(1):139-44. PubMed ID: 2334119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catharanthine C16 substituent effects on the biomimetic coupling with vindoline: preparation and evaluation of a key series of vinblastine analogues.
    Tam A; Gotoh H; Robertson WM; Boger DL
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6408-10. PubMed ID: 20932748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on microtubules in vitro.
    Himes RH; Kersey RN; Heller-Bettinger I; Samson FE
    Cancer Res; 1976 Oct; 36(10):3798-802. PubMed ID: 954003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and antiproliferativeactivity of new vinca alkaloids containing an α,β-unsaturated aromatic side chain.
    Ngo QA; Nguyen le A; Vo NB; Nguyen TH; Roussi F; Nguyen TH; Nguyen VT
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5597-600. PubMed ID: 26522953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Total synthesis of vinblastine, vincristine, related natural products, and key structural analogues.
    Ishikawa H; Colby DA; Seto S; Va P; Tam A; Kakei H; Rayl TJ; Hwang I; Boger DL
    J Am Chem Soc; 2009 Apr; 131(13):4904-16. PubMed ID: 19292450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural plasticity of tubulin assembly probed by vinca-domain ligands.
    Ranaivoson FM; Gigant B; Berritt S; Joullié M; Knossow M
    Acta Crystallogr D Biol Crystallogr; 2012 Aug; 68(Pt 8):927-34. PubMed ID: 22868758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions of the catharanthus (Vinca) alkaloids with tubulin and microtubules.
    Himes RH
    Pharmacol Ther; 1991; 51(2):257-67. PubMed ID: 1784631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential mechanisms of resistance to microtubule inhibitors.
    Kavallaris M; Annereau JP; Barret JM
    Semin Oncol; 2008 Jun; 35(3 Suppl 3):S22-7. PubMed ID: 18538175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The high-resolution X-ray structure of vinca-domain inhibitors of microtubules provides a rational approach for drug design.
    Chengyong W; Jinghong X; Yanyan W; Qing-Jie X; Lingling M; Yuyan L; Hai C; Qian L; Quan Z; Bo S; Yuxi W
    FEBS Lett; 2021 Jan; 595(2):195-205. PubMed ID: 33220079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic selectivity of vinca alkaloids: a role for guanosine 5'-triphosphate?
    Houghton PJ; Houghton JA; Bowman LC; Hazelton BJ
    Anticancer Drug Des; 1987 Oct; 2(2):165-79. PubMed ID: 3329524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.